DexCom Inc (DXCM) — Cash Flow Reinvestment Rate
DexCom Inc (DXCM) has a Cash Flow Reinvestment Rate of 0.57x as of March 2026, reinvesting $298.50 Million (capex $76.60 Million plus investments $-221.90 Million) from operating cash flow of $525.60 Million. Check DXCM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DexCom Inc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for DexCom Inc across 13 annual periods. Explore DexCom Inc (DXCM) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for DexCom Inc (2013–2025)
Year-by-year capital reinvestment analysis for DexCom Inc. For live market cap and broader valuation context, see market cap of DexCom Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $1.26 Billion | $1.44 Billion | $363.50 Million | ▲ +53.1% |
| 2024 | 0.57x | $566.30 Million | $989.50 Million | $358.80 Million | ▼ -68.3% |
| 2023 | 1.81x | $1.35 Billion | $748.50 Million | $236.60 Million | ▲ +140.4% |
| 2022 | 0.75x | $503.30 Million | $669.50 Million | $364.80 Million | ▼ -42.9% |
| 2021 | 1.32x | $582.40 Million | $442.50 Million | $389.20 Million | ▼ -37.8% |
| 2020 | 2.12x | $1.01 Billion | $475.60 Million | $199.00 Million | ▼ -34.4% |
| 2019 | 3.23x | $1.02 Billion | $314.50 Million | $180.00 Million | ▲ +209.5% |
| 2018 | 1.04x | $128.50 Million | $123.20 Million | $67.10 Million | ▼ -33.5% |
| 2017 | 1.57x | $144.40 Million | $92.00 Million | $66.00 Million | ▲ +57.0% |
| 2016 | 1.00x | $56.20 Million | $56.20 Million | $55.70 Million | ▼ -3.9% |
| 2015 | 1.04x | $51.00 Million | $49.00 Million | $33.30 Million | ▲ +46.2% |
| 2014 | 0.71x | $16.80 Million | $23.60 Million | $16.20 Million | ▼ -95.3% |
| 2013 | 15.29x | $36.70 Million | $2.40 Million | $7.90 Million | — |